CANCER THERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Cancer Therapy Market, By Therapy Type (Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Liver Cancer, Thyroid Cancer, Head and Neck Cancer, Skin Cancer, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 03 Apr, 2026
Code: CMI5335
Page number: 174
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Therapy Type
  - Market Snapshot, By Cancer Type
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Acquisitions and Partnerships Scenario
- Reimbursement Scenario
- Epidemiology
- Treatment Algorithm (Patient Journey)
- Cancer Diagnosis and Treatment Options
- Pipeline Analysis
- Patient Advocacy and Empowerment
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
- PORTER’s Analysis
Global Cancer Therapy Market, By Therapy Type, 2021 – 2033, (USD Bn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Chemotherapy
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    - Alkylating agents
    - Antimetabolites
    - Anti-tumor antibiotics
    - Others
- Target Therapy
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    - Monoclonal antibodies
    - Small molecule inhibitors
    - Others
- Immunotherapy
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    - Immune Checkpoint Inhibitors
    - Oncolytic virus therapy
    - T-cell therapy
- Radiotherapy
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Global Cancer Therapy Market, By Cancer Type, 2021 – 2033, (USD Bn)
- Overview
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Breast Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Lung Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Colorectal Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Prostate Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Blood Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Liver Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Thyroid Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Head and Neck Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Skin Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Global Cancer Therapy Market, By Region, 2021 – 2033, (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Region, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Bristol-Myers Squibb Company
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - AstraZeneca
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Pfizer Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Novartis AG
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - GSK plc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sanofi
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Bayer AG
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Amgen Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Gilead Sciences, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Boehringer Ingelheim International GmbH.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - ADC Therapeutics SA
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - F. Hoffmann-La Roche Ltd
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Merck & Co., Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Eureka Therapeutics, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - AbbVie Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Fate Therapeutics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sorrento Therapeutics, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Carrick Therapeutics Limited
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Atara Biotherapeutics, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Celluris
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - NeoTX
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Kazia Therapeutics Limited
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 48 market data tables and 44 figures on “Cancer Therapy Market” - Global forecast to 2033

Instant Download - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now